MedPath

Trial of Internet-Based Cognitive Behavioral Therapy for Insomnia

Not Applicable
Completed
Conditions
Insomnia
Interventions
Behavioral: Internet cognitive behavioral therapy for insomnia (iCBTI)
Behavioral: Class in sleeping well and improving insomnia
Registration Number
NCT03313466
Lead Sponsor
Kaiser Permanente
Brief Summary

The investigators will conduct a randomized, controlled trial of internet-based cognitive behavioral therapy (iCBT) vs usual care for insomnia. The target population is patients prescribed medications for insomnia who have not had a dispensation of these medications in the preceding six months. The primary outcomes is dispensed days supply over the subsequent one year. Secondary outcomes include all types of health system clinical encounters. The investigators hypothesize that the group randomized into iCBT will have less insomnia medications dispensed than usual care controls, and less clinical encounters..

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
136630
Inclusion Criteria
  • A prescription for any of a set of selected insomnia medications.
  • Age >18 years at the time of the prescription.
  • A recent (<30 days before the prescription date) diagnosis of insomnia as determined by a set of selected International Classification of Disease (ICD) codes, to be used for medications that are not prescribed just for insomnia.
  • Membership for >365 days prior to the prescription date.
  • No evidence of a dispensed insomnia medication within six months (183 days) of the current prescription.
Exclusion Criteria
  • Contained in inclusion criteria.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
iCBTIInternet cognitive behavioral therapy for insomnia (iCBTI)Intervention: An internet-based cognitive behavioral therapy program for insomnia (iCBTI) that is tailored to the individual's needs based on responses to questions.
Usual careClass in sleeping well and improving insomniaIntervention: A group class on insomnia provided at each Kaiser Permanente Southern California medical center.
Primary Outcome Measures
NameTimeMethod
Days supply of dispensed insomnia medicationsOne year

Days supply of dispensed insomnia medications up to one year after randomization.

Secondary Outcome Measures
NameTimeMethod
Health care inpatient and outpatient encountersOne year

Number of physician or mid-level provider encounters (face-to-face, telephone, video): (1) outpatient, (2) acute care: emergency, inpatient, up to one year after randomization.

Trial Locations

Locations (1)

Kaiser Permanente Southern California

🇺🇸

Pasadena, California, United States

© Copyright 2025. All Rights Reserved by MedPath